ALS (motor neurone disease) trials, also abroad
226 open ALS (motor neurone disease) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients has 1 site in Norway and runs in 17 countries. If a site near you is full, another one may still take people.
See Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients in all 17 countries